Growth Metrics

Collegium Pharmaceutical (COLL) Total Current Liabilities (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Total Current Liabilities data on record, last reported at $452.9 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 1.41% year-over-year to $452.9 million; the TTM value through Sep 2025 reached $452.9 million, down 1.41%, while the annual FY2024 figure was $509.5 million, 11.27% up from the prior year.
  • Total Current Liabilities reached $452.9 million in Q3 2025 per COLL's latest filing, down from $464.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $509.5 million in Q4 2024 and bottomed at $226.8 million in Q2 2021.
  • Average Total Current Liabilities over 5 years is $405.0 million, with a median of $435.1 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: fell 10.02% in 2021, then surged 82.99% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $279.6 million in 2021, then surged by 55.14% to $433.7 million in 2022, then grew by 5.58% to $457.9 million in 2023, then rose by 11.27% to $509.5 million in 2024, then decreased by 11.1% to $452.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $452.9 million in Q3 2025, $464.6 million in Q2 2025, and $486.7 million in Q1 2025.